Opening book details…
About this Medicine article
Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: The Lira-1 study by Dejgaard, T. F.; Knop, F. K.; Tarnow, L.; Frandsen, C. S.; Hansen, T. S.; Almdal, T.; Holst, J. J.; Madsbad, S.; Andersen, H. U. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Dejgaard, T. F.; Knop, F. K.; Tarnow, L.; Frandsen, C. S.; Hansen, T. S.; Almdal, T.; Holst, J. J.; Madsbad, S.; Andersen, H. U.
- Publisher
- BMJ; BMJ Publishing Group; London: BMJ Publishing (ISSN 2044-6055)
- Published
- 2015
- Language
- EN
- Field
- Medicine (Health Sciences)